.png)
Biotech Investment Analyst - Drug Asset & Company Assessment
Original posting at apply.workable.com — the employer has removed it, so the link may no longer work.
What we know
Is it still open?
Confirmed removed at the source
Last checked 9h ago — checked against the employer's own applicant tracking system, which is the company answering directly.
How old is it?
Posted 47d ago
The date the source published, not the day we noticed it (2026-09-17). Last seen at its source 15h ago.
Is it remote?
Marked remote on the employer's board
Their board carries a remote setting on this posting — a field they filled in, not wording we read. The location field names somewhere specific, which is usually where the team or the entity sits.
Who may apply?
United States
The description agrees: it names United States.
What the ad says
…US-based US-based Why Participate Help improve expert AI evaluation of drugs…
Pay
$120–200/hr
Read out of the job description by us, not from a structured field. Shown in the posting's own currency and period; we never convert.
Skills named in the ad
Recognised terms only, from a fixed vocabulary — this is what CV matching compares against.
Carried by 1 source
-
Workable employer's own board first seen 46d ago · last seen 15h ago
The listing
This role is for one of our clients
Compensation: $120 - $200 per hour
We are partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.
Requirements
Responsibilities
- Create and critique rubrics that analyze commercial drugs and drug-development programs
- Provide overall company and asset assessment — mechanism, clinical data, competitive position, and value drivers
- Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions
- Apply your assessment across the pilot's set of companies (~5–10)
Requirements
- US-based biotech / healthcare investment analyst with a specialist-fund background
- Familiarity with biotech/pharma development programs
- Able to assess a drug asset and the company behind it end-to-end
- 5+ years evaluating biotech/pharma companies or assets
Engagement Details
- Duration: Approximately 10–20 hours over a 1–2 week pilot
- Remote — US-based
Why Participate
- Help improve expert AI evaluation of drugs and drug-development programs
- Recurring engagement for strong contributors
We consider all qualified applicants without regard to legally protected characteristics and provide reasonable accommodations upon request.